Stay updated with breaking news from Genmark Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WILMINGTON, Del., March 15, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating GenMark Diagnostics, Inc. ("GenMark") (NASDAQ ...
A healthcare titan is acquiring the diagnostic-test maker for a hefty premium.
Deal confirms reports that GenMark was an acquisition target; company makes tests to detect a range of respiratory ailments such flu strains, COVID-19 strains and others from a single sample
POLITICO Get the Prescription Pulse newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Presented by Pharmaceutical Care Management Association With Susannah Luthi, Brianna Ehley and Emily Martin On Tap — Biden hikes Medicare payments for Covid shots to get more providers on board. — CMS delays device rule, disappointing...
ZURICH (Reuters) - Roche will buy GenMark Diagnostics, a U.S.-based maker of molecular diagnostic tests in a $1.8 billion deal, the Swiss pharmaceutic...